Schwann cell-derived CXCL1 contributes to human immunodeficiency virus type 1 gp120-induced neuropathic pain by modulating macrophage infiltration in mice

Schwann cell-derived CXCL1 contributes to human immunodeficiency virus type 1 gp120-induced neuropathic pain by modulating macrophage infiltration in mice
复制标题

DOI:
10.1016/j.bbi.2020.03.027
复制
发表时间:
2020-08-01
影响因子:
15.1
通讯作者:
Matsubara,Kazuo
Matsubara,Kazuo
中科院分区:
医学1区
文献类型:
--
作者:
Ntogwa,Mpumelelo;Imai,Satoshi;Matsubara,Kazuo

文献摘要

被引文献

相似文献

对人类免疫缺陷病毒1型(HIV-1)外壳蛋白(如糖蛋白120(gp 120))的神经炎症反应被认为是HIV相关远端感觉神经病变的原因。越来越多的证据表明,T细胞系嗜性X4 gp 120增加巨噬细胞浸润到周围神经,从而诱导神经炎症导致疼痛。然而,X4 gp 120诱导巨噬细胞募集到周围神经系统的机制仍不清楚。在这里,我们证明了神经周围应用来自HIV-1株IIIB和MN的X4 gp 120引起小鼠的机械超敏反应和自发性疼痛样行为。此外,流式细胞术和免疫组织化学研究显示,在gp 120 IIIB或MN应用后7天,骨髓源性巨噬细胞向坐骨神经和背根神经节(DRG)实质中的浸润增加。化学删除循环巨噬细胞使用氯膦酸盐脂质体显着抑制gp 120 IIIB诱导的疼痛样行为。在体外细胞浸润分析中,RAW 264.7细胞(鼠巨噬细胞系)是chemoattractive条件培养基从gp 120 IIIB或MN处理培养的雪旺细胞,但不从这些gp 120处理的DRG神经元的条件培养基,表明可能参与雪旺细胞衍生的可溶性因子在巨噬细胞浸润。我们确定使用基因表达阵列,CXCL 1,巨噬细胞和中性粒细胞的趋化因子,增加在gp 120 IIIB处理培养的雪旺细胞。类似于gp 120 IIIB或MN,神经周围应用重组CXCL 1引起疼痛样行为,伴随着巨噬细胞浸润到周围神经。此外,重复注射CXCR 2(CXCL 1受体)拮抗剂或CXCL 1中和抗体可预防gp 120 IIIB治疗小鼠的疼痛样行为和巨噬细胞浸润。因此,本研究新定义了雪旺细胞衍生的CXCL 1,响应于X4 gp 120暴露而分泌,负责巨噬细胞浸润到外周神经中,从而与小鼠的疼痛样行为相关。我们在此提出,许旺细胞和巨噬细胞之间的通信可能在诱导X4 HIV-1相关疼痛中发挥重要作用。
The neuroinflammatory responses to human immunodeficiency virus type 1 (HIV-1) coat proteins, such as glycoprotein 120 (gp120), are considered to be responsible for the HIV-associated distal sensory neuropathy. Accumulating evidences suggest that T-cell line tropic X4 gp120 increases macrophage infiltration into the peripheral nerves, and thereby induces neuroinflammation leading to pain. However, the mechanisms underlying X4 gp120-induced macrophage recruitment to the peripheral nervous systems remain unclear. Here, we demonstrated that perineural application of X4 gp120 from HIV-1 strains IIIB and MN elicited mechanical hypersensitivity and spontaneous pain-like behaviors in mice. Furthermore, flow cytometry and immunohistochemical studies revealed increased infiltration of bone marrow-derived macrophages into the parenchyma of sciatic nerves and dorsal root ganglia (DRG) 7 days after gp120 IIIB or MN application. Chemical deletion of circulating macrophages using clodronate liposomes markedly suppressed gp120 IIIB-induced pain-like behaviors. Inin vitrocell infiltration analysis, RAW 264.7 cell (a murine macrophage cell line) was chemoattracted to conditioned medium from gp120 IIIB- or MN-treated cultured Schwann cells, but not to conditioned medium from these gp120-treated DRG neurons, suggesting possible involvement of Schwann cell-derived soluble factors in macrophage infiltration. We identified using a gene expression array that CXCL1, a chemoattractant of macrophages and neutrophils, was increased in gp120 IIIB-treated cultured Schwann cells. Similar to gp120 IIIB or MN, perineural application of recombinant CXCL1 elicited pain-like behaviors accompanied by macrophage infiltration to the peripheral nerves. Furthermore, the repeated injection of CXCR2 (receptor for CXCL1) antagonist or CXCL1 neutralizing antibody prevented both pain-like behaviors and macrophage infiltration in gp120 IIIB-treated mice. Thus, the present study newly defines that Schwann cell-derived CXCL1, secreted in response to X4 gp120 exposure, is responsible for macrophage infiltration into peripheral nerves, and is thereby associated with pain-like behaviors in mice. We propose herein that communication between Schwann cells and macrophages may play a prominent role in the induction of X4 HIV-1-associated pain.